"I was delighted to take part in a clinical trial as it has the potential to really help others in the future.”
A trial looking at zalutumumab with radiotherapy for head and neck cancer (GEN207)
This trial was looking at zalutumumab with radiotherapy for cancer of the mouth or cancer of the voice box (larynx) that is locally advanced.
Doctors often treat locally advanced cancer of the mouth or cancer of the larynx with chemotherapy and radiotherapy together. They most often use
Zalutumumab is a type of biological therapy called a monoclonal antibody. We knew from
The aim of this trial was to find the
Summary of results
This trial was never finished so there are no results available.
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Chris Nutting
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040